Treatment Options for Hepatobiliary and Pancreatic Cancer

This publication has 79 references indexed in Scilit:

• Surgical management of hilar cholangiocarcinoma: the Nagoya experience
  HPB, 2005
• A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma
  JNCI Journal of the National Cancer Institute, 2005
• Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial
  Journal of Clinical Oncology, 2005
• Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
  Hepatology, 2003
• Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
  The Lancet, 2002
• Gemcitabine for the Treatment of Advanced Biliary Tract Carcinomas: Evaluation of Two Different Dose Regimens
  Oncology Research and Treatment, 1999
• Durable Clinical and Pathologic Response of Hepatocellular Carcinoma to Systemic and Hepatic Arterial Administration of Platinol, Recombinant Interferon α 2B, Doxorubicin, and 5-Fluorouracil
  American Journal of Clinical Oncology, 1999
• Tamoxifen inhibits hepatoma cell growth through an estrogen receptor independent mechanism
  Journal of Hepatology, 1995
• Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma
  Published by Elsevier ,1994
• Sex hormone receptors in hepatocellular carcinoma: Is there a rationale for hormonal treatment?
  Journal of Hepatology, 1993